Literature DB >> 10951568

Aberrant cell cycle progression contributes to the early-stage accelerated carcinogenesis in transgenic epidermis expressing the dominant negative TGFbetaRII.

C Go1, W He, L Zhong, P Li, J Huang, B R Brinkley, X J Wang.   

Abstract

Mutations in the transforming growth factor beta type II receptor (TGFbetaRII) have been found in various malignant tumors, suggesting that loss of TGFbeta signaling plays a causal role in late-stage cancer development. To test whether loss of TGFbetaRII is involved in early-stage carcinogenesis, we have generated transgenic mice expressing a dominant negative TGFbetaRII (deltabetaRII) in the epidermis. These mice exhibited an increased susceptibility to chemical carcinogenesis protocols at both early and late stages. In the current study, parameters for cell cycle progression and chromosome instability were analysed in deltabetaRII tumors. DeltabetaRII papillomas showed an increased S phase in flow cytometry. Bromodeoxyuridine (BrdU) labeling and mitotic indices in deltabetaRII papillomas also showed a threefold increase compared to papillomas developing in non-transgenic mice. When papillomas further progressed to squamous cell carcinomas (SCC), both control and deltabetaRII SCC showed similar BrdU labeling indices and percentages of S phase cells. However, deltabetaRII SCC cells showed a sixfold increase in the G2/M population. Mitotic indices in deltabetaRII SCC also showed a threefold increase compared to non-transgenic SCC. Consistent with a perturbed cell cycle, deltabetaRII papillomas and SCC showed reduced expression of the TGFbeta target genes p15 (INK4b), p21 (WAF-1) and p27 (Kip1), inhibitors of cyclin-dependent kinases (cdks). However, most deltabetaRII papilloma cells exhibited normal centrosome numbers, and deltabetaRII SCC exhibited a similar extent of centrosome abnormalities compared to control SCC (35-40% cells). Most of deltabetaRII SCC exhibited diploid chromosome profiles. These data indicate that inactivation of TGFbetaRII accelerates skin tumorigenesis at early stages by the acceleration of loss of cell cycle control, but not by increased chromosome instability.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10951568     DOI: 10.1038/sj.onc.1203701

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  6 in total

1.  Epithelial stem cell mutations that promote squamous cell carcinoma metastasis.

Authors:  Ruth A White; Jill M Neiman; Anand Reddi; Gangwen Han; Stanca Birlea; Doyel Mitra; Laikuan Dionne; Pam Fernandez; Kazutoshi Murao; Li Bian; Stephen B Keysar; Nathaniel B Goldstein; Ningjing Song; Sophia Bornstein; Zheyi Han; Xian Lu; Joshua Wisell; Fulun Li; John Song; Shi-Long Lu; Antonio Jimeno; Dennis R Roop; Xiao-Jing Wang
Journal:  J Clin Invest       Date:  2013-09-03       Impact factor: 14.808

2.  Overexpression of Smad7 results in severe pathological alterations in multiple epithelial tissues.

Authors:  Wei He; Allen G Li; Dongyan Wang; Shuhua Han; Biao Zheng; Marie-José Goumans; Peter Ten Dijke; Xiao-Jing Wang
Journal:  EMBO J       Date:  2002-06-03       Impact factor: 11.598

3.  Distinct mechanisms of TGF-beta1-mediated epithelial-to-mesenchymal transition and metastasis during skin carcinogenesis.

Authors:  Gangwen Han; Shi-Long Lu; Allen G Li; Wei He; Christopher L Corless; Molly Kulesz-Martin; Xiao-Jing Wang
Journal:  J Clin Invest       Date:  2005-06-02       Impact factor: 14.808

4.  Use of a TGFbeta type I receptor inhibitor in mouse skin carcinogenesis reveals a dual role for TGFbeta signaling in tumor promotion and progression.

Authors:  Lauren Mordasky Markell; Rolando Pérez-Lorenzo; Katelyn E Masiuk; Mary J Kennett; Adam B Glick
Journal:  Carcinogenesis       Date:  2010-09-17       Impact factor: 4.944

5.  Loss of TGFbeta signaling destabilizes homeostasis and promotes squamous cell carcinomas in stratified epithelia.

Authors:  Géraldine Guasch; Markus Schober; H Amalia Pasolli; Emily Belmont Conn; Lisa Polak; Elaine Fuchs
Journal:  Cancer Cell       Date:  2007-10       Impact factor: 31.743

6.  The Role of TGFβ Signaling in Squamous Cell Cancer: Lessons from Mouse Models.

Authors:  Adam B Glick
Journal:  J Skin Cancer       Date:  2012-12-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.